EU Pharmaceutical Committee meeting considers main issues raised by coronavirus (COVID-19)

EU Pharmaceutical Committee meeting considers main issues raised by coronavirus (COVID-19)

The European Commission Health and Food Safety Directorate-General has released a summary record of the Pharmaceutical Committee’s 87th meeting on 26 May 2020. The focal point of the meeting was the coronavirus (COVID-19) pandemic, in order to focus policy activities on crisis management, but also learn from the crisis. The main issues raised during the meeting concerned the availability of medicines, dependency from third countries for pharmaceutical ingredients and products, personal protection equipment and essential medicines and equipment stockpiling, as well as crisis management mechanisms. A summary record of the 88th meeting of the Pharmaceutical Committee, held on 2 July 2020, will be published once adopted by the Committee.

Participants, which included representatives from the Commission, 24 EU Member States, Norway, Iceland and the European Medicines Agency, agreed that the EU needs greater co-ordination, clarity about each actor’s role and increased transparency regarding medicines stocks and needs.

Read the summary record of the 97th meeting here.

Source: Human Pharmaceutical Committee – Meetings

Related Articles:
Latest Articles: